Who pays for screening?

Government funding essential if pharmacy COPD screening is to be sustainable, as fears remain over charging patients   While a number of clinical trials have revealed the efficacy of pharmacist-led COPD screening, there remain a number of barriers stopping the service being a wide-ranging success, researchers say. The most common barriers identified by pharmacists who had

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Pharmacy stalwarts receive TWCM honours
Next My big Canadian pharmacy adventure